Skip to main content
Glama

Temperature Random

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (readOnly, openWorld, idempotent), the description discloses data sources (SEC EDGAR/XBRL, FAERS, FDA), handling of fiscal year variances, sorting by primary metric, and return of citation URIs. No contradictions with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is well-structured, front-loaded with example queries, and every sentence adds value. It efficiently conveys usage, behavior, and output without redundancy.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The tool has two simple parameters and no output schema, but the description covers all key aspects: input requirements, data sources, sorting, and return format (paired data + citation URIs). It also quantifies efficiency gains (replaces 8-15 lookups).

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description significantly enriches both parameters. For 'type', it specifies exact financial metrics for company and adverse events for drug. For 'values', it provides concrete examples (tickers, CIKs, drug names). This adds substantial meaning beyond schema descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: side-by-side comparison of 2-5 companies or drugs. It lists example queries and explicitly distinguishes itself from sequential single-pack lookups, making the purpose unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit guidance on when to use (comparison, ranking, head-to-head) and when to avoid alternatives (prefer over sequential lookups). It also explains type-specific behavior and suggests the appropriate number of entities (2-5).

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

There are several overlapping clusters: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all route questions through the same 5,743-tool catalog, and ask_pipeworx_beta is currently an exact duplicate of ask_pipeworx. The Polymarket opportunity tools (polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread, bet_research) also have fuzzy boundaries despite detailed descriptions.

Naming Consistency2/5

There is no consistent naming pattern across the set: some tools are verb-first (ask_pipeworx, compare_entities, validate_claim), some are noun-first (entity_profile, recent_changes, polymarket_edges), and some are compound/multi-word oddities (temperature_random_generate, ai_visibility_check). Small internal clusters like remember/recall/forget and subscribe/unsubscribe/list_subscriptions show mini-consistency, but the overall convention is mixed and unpredictable.

Tool Count2/5

With 32 tools, the server is over-stuffed, and many of them serve the same broad Pipeworx data/research purpose while one unrelated temperature tool rides along. The count is above the 25-tool threshold where a set starts to feel unwieldy, and several tools could be merged or dropped without losing real capability.

Completeness4/5

Assuming the intended scope is the Pipeworx data/agent platform implied by 31 of the 32 tools, coverage is strong: lookups, grounded verification, deep research, entity profiles, comparisons, entity resolution, claim validation, tool discovery, memory, subscription lifecycle, prediction-market analysis, execution risk, and feedback are all represented. The temperature_random_generate tool is a domain misfit rather than a completeness gap, and there are few obvious missing operations for the stated workflows.